HDL and atherothrombotic vascular disease
Wijtske Annema1, Arnold von Eckardstein, Petri T Kovanen
1Institute of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland, wijtske.annema@usz.ch.
Handbook of Experimental Pharmacology
|December 20, 2014
Summary
High-density lipoproteins (HDL) offer protective effects against atherosclerosis by promoting cholesterol removal and preserving blood vessel function. Understanding HDL
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
- Atherosclerosis Research
Background:
- High-density lipoproteins (HDLs) possess multiple atheroprotective functions, including promoting cholesterol efflux, preventing low-density lipoprotein (LDL) modification, and exerting anti-inflammatory effects.
- The precise contribution of each HDL function to preventing or regressing atherosclerosis remains unclear.
- Inflammatory conditions can impair HDL functionality, leading to altered or lost protective activities.
Purpose of the Study:
- To investigate the complex structure-function relationships of HDL and its components.
- To clarify the relative importance of various HDL activities in atheroprotection.
- To identify HDL-related targets for anti-atherosclerotic therapies.
Main Methods:
- Analysis of HDL composition and associated lipid and protein molecules.
- Assessment of HDL functionality in various biological assays.
- Correlation of HDL structure with atheroprotective activities.
Main Results:
- HDLs exhibit diverse beneficial activities crucial for cardiovascular health.
- The complexity of HDL composition and functionality presents challenges in defining specific structure-function links.
- Inflammation significantly impacts HDL's protective capabilities.
Conclusions:
- A comprehensive understanding of HDL metabolism and structure-function is essential for developing novel anti-atherosclerotic strategies.
- Targeting HDL pathways and components may offer therapeutic potential for atherosclerosis.
- Further research is needed to elucidate specific HDL structure-function relationships for diagnostic and therapeutic applications.
Related Concept Videos
Atherosclerosis I: Introduction
2.3K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.3K
Peripheral Artery Disease I: Introduction
650
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
650
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
844
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
844
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.7K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.7K
Atherosclerosis III: Management
642
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Coronary Artery Disease II: Pathophysiology
1.0K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K


